Publication date: June 2026 Source: Clinical Colorectal Cancer, Volume 25, Issue 2 Author(s): Sergey S. Gordeyev, Marina V. Chernykh, Mikhail Yu. Fedyanin, Evgeny G. Rybakov, Nataliya S. Besova, Valerii A. Ivanov, Zaman Z. Mamedli
Randomized phase III Study of Adding Paclitaxel to Chemoradiotherapy With Capecitabine and Mitomycin C in Squamous Cell Anal Carcinoma. // Clinical Colorectal Cancer. – URL: https://www.sciencedirect.com/science/article/pii/S1533002826000022?dgcid=rss_sd_all
Randomized phase III Study of Adding Paclitaxel to Chemoradiotherapy With Capecitabine and Mitomycin C in Squamous Cell Anal Carcinoma. Clinical Colorectal Cancer. https://www.sciencedirect.com/science/article/pii/S1533002826000022?dgcid=rss_sd_all
“Randomized phase III Study of Adding Paclitaxel to Chemoradiotherapy With Capecitabine and Mitomycin C in Squamous Cell Anal Carcinoma.” Clinical Colorectal Cancer.
@article{article40739,
title = {Randomized phase III Study of Adding Paclitaxel to Chemoradiotherapy With Capecitabine and Mitomycin C in Squamous Cell Anal Carcinoma},
journal = {Clinical Colorectal Cancer},
url = {https://www.sciencedirect.com/science/article/pii/S1533002826000022?dgcid=rss_sd_all}
}